跳至主要内容
临床试验/NCT02747108
NCT02747108已完成不适用

Improving Veteran Engagement in Diabetes Prevention (CDA 13-267)

VA Office of Research and Development2 个研究点 分布在 1 个国家目标入组 315 人开始时间: 2015年12月2日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
315
试验地点
2
主要终点
Weight Change From Baseline to 12 Months

研究概览

简要总结

This study will evaluate the effects of screening for type 2 diabetes mellitus (T2DM) and brief counseling about screening test results on weight and key health behaviors among Veterans with risk factors for T2DM. Study participants will be randomly assigned to one of two study groups: (1) Blood Test Group or (2) Brochure Group. Participants in the Blood Test Group will complete a blood test called hemoglobin A1c (HbA1c) which measures average blood sugar levels. Participants will receive brief counseling about the results from their primary care provider or someone authorized to speak on their behalf. Participants randomly selected for the Brochure Group will review a handout from the VA National Center for Health Promotion and Disease Prevention (NCP) on recommended screening tests and immunizations. All participants will be asked to complete a survey prior to study group assignment, immediately after a Primary Care appointment, 3 months after enrollment, and 12 months after enrollment.

详细描述

An essential step in designing effective strategies to improve patient engagement in behavior change is to better understand their current levels of engagement in these behaviors and determine which factors most influence their engagement. Within and outside the Veterans Health Administration (VHA), little is known about how patients with risk factors for T2DM view their risk of developing T2DM, what these patients understand about strategies to reduce this risk, and to what degree at-risk patients are currently engaging in behaviors to prevent T2DM. This project will generate important new data in these areas and will improve the investigators' understanding of the effects of a prediabetes diagnosis and brief counseling on engagement in behaviors to prevent T2DM and mediators of these behaviors.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Investigator)

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • The investigators will recruit 315 non-diabetic Veterans receiving primary care at the Ann Arbor VA Medical Center who meet the following inclusion criteria:
  • willing to complete a HIPAA authorization form
  • no HbA1c results in previous 12 months
  • due for VA Primary Care appointment approximately 12 weeks of sending a recruitment letter and who have a body-mass index (BMI) 30 kg/m2
  • or BMI 25 kg/m2 with > 1 obesity-related condition such as:
  • hypertension
  • hyperlipidemia
  • Hypoalphalipoproteinemia
  • Coronary Artery Disease
  • Peripheral Vascular Disease
  • Hypertriglyceridemia
  • past hemoglobin A1c (HbA1c) of 5.7 - 6.4
  • past diagnosis of Impaired Fasting Glucose (IFG)
  • or Impaired Glucose Tolerance (IGT)
  • or Polycystic Ovary Syndrome (PCOS)

排除标准

  • The investigators will exclude patients who are > 75 years of age
  • are receiving chemotherapy for cancer, or have:
  • New York Heart Association Class III or IV congestive heart failure
  • pregnancy
  • Global Initiative for Chronic Obstructive Lung Disease (GOLD) stage 4 Chronic Obstructive Pulmonary Disease (COPD)
  • end-stage renal disease (ESRD)
  • cirrhosis
  • or have been hospitalized or received rehab for stroke or myocardial infarction within the past 6 months

结局指标

主要结局

Weight Change From Baseline to 12 Months

时间窗: 12 months

The primary outcome will be weight change 12 months after an HbA1c test and brief counseling or review of health promotion literature.

次要结局

  • Change in Use of Medication for T2DM Prevention(3 and 12 months)
  • Changes in Participation in a Weight Management Program(3 months and 12 months)
  • Changes in Perception for Risk for T2DM(Baseline, 2 weeks, 3 months, and 12 months)
  • Changes in Knowledge of Strategies to Prevent T2DM(2 weeks, 3 months, and 12 months)
  • Changes in Motivation to Prevent T2DM(Baseline, 2 weeks, 3 months, and 12 months)
  • Changes in Self-efficacy to Engage in Behaviors to Prevent T2DM(Baseline, 3 months and 12 months)
  • Change in Physical Activity(Baseline, 3 months and 12 months)
  • Change in Mental Health(Baseline, 2 weeks, 3 months, and 12 months)

研究者

申办方类型
Fed
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

ForgIng New Paths to Prevent DIabeTes (FINDIT) | 临床试验